サンプル依頼リスト カート
  • English
  • Korean
表紙：創薬インフォマティクスの世界市場規模調査・予測：ワークフロー別、サービス別、地域別分析、2023-2030年
市場調査レポート
商品コード
1418753

創薬インフォマティクスの世界市場規模調査・予測：ワークフロー別、サービス別、地域別分析、2023-2030年

Global Drug Discovery Informatics Market Size study & Forecast, by Workflow, by Services and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
創薬インフォマティクスの世界市場規模調査・予測：ワークフロー別、サービス別、地域別分析、2023-2030年
出版日: 2024年01月10日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の創薬インフォマティクス市場は、2022年に約29億6,000万米ドルと評価され、予測期間2023～2030年には11.2%以上の健全な成長率で成長すると予測されています。

創薬インフォマティクスは、計算技術や情報技術を活用して創薬プロセスを合理化・強化する学際的な分野です。これには、ゲノム、プロテオミクス、化学構造に関連する情報が含まれます。創薬インフォマティクスには、バイオインフォマティクス、ケムインフォマティクス、システム生物学など、潜在的な薬剤候補の同定や作用機序の理解を助ける様々な計算アプローチが含まれます。創薬インフォマティクス市場は、製薬企業やバイオテクノロジー企業による研究開発費の高騰、創薬プラットフォームの技術進歩の増加、前臨床研究開発の活発化などの要因により拡大しています。

市場は、創薬開発に専念する製薬企業やバイオテクノロジー企業による多額の研究開発投資などの要因によって成長を遂げています。データマイニングとアナリティクスに関する技術的進歩も著しいです。例えば、Automata Labsは実験室の調査方法を自動化するために2022年2月に5,000万米ドルを確保し、StrateosはSmartLabプラットフォームを強化し、前臨床研究者のための遠隔ロボット化自動化を世界に展開するために2021年7月に5,600万米ドルを調達しました。さらに2022年3月には、創薬スタートアップのArrePathが、ベーリンガーインゲルハイム・ベンチャーファンド、Insight Partners、Innospark Venturesが主導するシード資金として2,000万米ドルを確保しました。この資金調達により、ArrePath社の機械学習ベースの創薬プラットフォームが強化され、特に抗菌薬耐性に対処するための新規抗感染症薬の開発に注力することになります。研究開発投資の継続的な増加により、市場は予測期間を通じて成長する態勢が整っています。また、データマイニングと分析における技術的進歩や創薬活動の増加が、市場成長の新たな機会を生み出しています。しかし、創薬インフォマティクスのコストが高いことが、2023～2030年の予測期間を通じて市場の成長を阻害しています。

創薬インフォマティクスの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、創薬に焦点を当てた研究開発（R&D）活動への投資の増加や、データマイニングおよび分析技術の進歩により、2022年に最大の市場シェアを獲得し、市場を独占しました。アジア太平洋地域は、製薬・バイオ医薬品産業の急成長や、同地域におけるCRO数の拡大などの要因により、予測期間中に大きく成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における業界の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の創薬インフォマティクス市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 創薬インフォマティクスの世界市場力学

  • 創薬インフォマティクス市場の影響分析（2020～2030年）
    • 市場促進要因
      • 製薬企業やバイオテクノロジー企業による研究開発費の高騰
      • 創薬プラットフォームの技術進歩の増加
      • 前臨床研究開発の増加
    • 市場の課題
      • 創薬インフォマティクスの高コスト
      • データセキュリティとプライバシーに関する懸念
    • 市場機会
      • データマイニングとアナリティクスの技術的進歩
      • 創薬活動の増加

第4章 世界の創薬インフォマティクス市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治的
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 創薬インフォマティクスの世界市場：ワークフロー別

  • 市場スナップショット
  • 創薬インフォマティクスの世界市場：ワークフロー別、実績 - ポテンシャル分析
  • 創薬インフォマティクスの世界市場：ワークフロー別推定・予測、2020年～2030年
  • 創薬インフォマティクス市場、サブセグメント分析
    • 創薬インフォマティクス
    • バイオコンテンツ管理

第6章 創薬インフォマティクスの世界市場：サービス別

  • 市場スナップショット
  • 創薬インフォマティクスの世界市場：サービス別、実績 - ポテンシャル分析
  • 創薬インフォマティクスの世界市場：サービス別推定・予測、2020～2030年
  • 創薬インフォマティクス市場、サブセグメント分析
    • シーケンス解析プラットフォーム
    • 分子モデリング
    • ドッキング
    • 臨床試験データ管理
    • その他

第7章 創薬インフォマティクスの世界市場、地域分析

  • 主要国
  • 主な新興国
  • 創薬インフォマティクス市場、地域別市場スナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東・アフリカ

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • PerkinElmer Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Charles River
    • Infosys Limited
    • International Business Machines Corporation（IBM）
    • Tata Consultancy Services Limited
    • Amazon Web Services
    • Schrodinger LLC.
    • Boehringer Ingelheim International GmbH
    • CORE INFORMATICS
    • Informatics Matters Ltd.,

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Drug Discovery Informatics Market, report scope
  • TABLE 2. Global Drug Discovery Informatics Market estimates & forecasts by region 2020-2030 (USD Billion)
  • TABLE 3. Global Drug Discovery Informatics Market estimates & forecasts by Workflow 2020-2030 (USD Billion)
  • TABLE 4. Global Drug Discovery Informatics Market estimates & forecasts by Services 2020-2030 (USD Billion)
  • TABLE 5. Global Drug Discovery Informatics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 6. Global Drug Discovery Informatics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Drug Discovery Informatics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Drug Discovery Informatics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Drug Discovery Informatics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Drug Discovery Informatics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Drug Discovery Informatics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Drug Discovery Informatics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Drug Discovery Informatics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Drug Discovery Informatics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. U.S. Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 17. U.S. Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. Canada Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. Canada Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. UK Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. UK Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. Germany Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. Germany Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. France Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. France Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. Italy Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. Italy Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Spain Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Spain Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. RoE Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. RoE Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. China Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. China Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. India Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. India Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. Japan Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. Japan Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. South Korea Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. South Korea Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. Australia Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. Australia Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. RoAPAC Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. Brazil Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. Brazil Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Mexico Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Mexico Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. RoLA Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. RoLA Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. Saudi Arabia Drug Discovery Informatics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. South Africa Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoMEA Drug Discovery Informatics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Drug Discovery Informatics Market
  • TABLE 70. List of primary sources, used in the study of global Drug Discovery Informatics Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable.

LIST OF FIGURES

  • FIG 1. Global Drug Discovery Informatics Market, research methodology
  • FIG 2. Global Drug Discovery Informatics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Drug Discovery Informatics Market, key trends 2022
  • FIG 5. Global Drug Discovery Informatics Market, growth prospects 2023-2030
  • FIG 6. Global Drug Discovery Informatics Market, porters 5 force model
  • FIG 7. Global Drug Discovery Informatics Market, pest analysis
  • FIG 8. Global Drug Discovery Informatics Market, value chain analysis
  • FIG 9. Global Drug Discovery Informatics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Drug Discovery Informatics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Drug Discovery Informatics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Drug Discovery Informatics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Drug Discovery Informatics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Drug Discovery Informatics Market, regional snapshot 2020 & 2030
  • FIG 15. North America Drug Discovery Informatics Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Drug Discovery Informatics Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Drug Discovery Informatics Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Drug Discovery Informatics Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Drug Discovery Informatics Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable.

目次

Global Drug Discovery Informatics Market is valued at approximately USD 2.96 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 11.2% over the forecast period 2023-2030. Drug discovery informatics is a multidisciplinary field that leverages computational and informational technologies to streamline and enhance the drug discovery process. This includes information related to genomics, proteomics, and chemical structures. Drug discovery informatics encompasses various computational approaches such as bioinformatics, cheminformatics and systems biology, which aid in the identification of potential drug candidates and understanding their mechanisms of action. The Drug Discovery Informatics market is expanding because of factors such as high R&D expenditure by pharmaceutical and biotechnology companies, increasing technological advancement in drug discovery platforms and rising pre-clinical research and development.

The market is experiencing growth driven by factors such as substantial research and development investments from pharmaceutical and biotechnology companies dedicated to drug discovery and development. There is a notable surge in the technological advancements related to data mining and analytics. For instance, Automata Labs securing USD 50 million in February 2022 to automate laboratory research processes, and Strateos raising USD 56 million in July 2021 to enhance its SmartLab platform and deploy remote robotized automation for preclinical researchers globally. Additionally, in March 2022, drug discovery startup ArrePath secured USD 20 million in seed funding, led by the Boehringer Ingelheim Venture Fund, Insight Partners, and Innospark Ventures. This funding will bolster ArrePath's machine learning-based drug discovery platform, specifically focusing on developing novel anti-infective drugs to address antimicrobial resistance. With a continuous uptick in research and development investments, the market is poised for growth throughout the forecast period. In addition, technological advancements in data mining and analytics and rising number of drug discovery activities are creating new opportunities for the market growth. However, the high cost of drug discovery informatics stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Drug Discovery Informatics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to increasing investments in research and development (R&D) activities focused on drug discovery and the advancements in data mining and analytics technologies. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rapid growth of pharmaceutical and biopharmaceutical industries and the expanding number of CROs in the region.

Major market player included in this report are:

  • PerkinElmer Inc.
  • Charles River
  • Infosys Limited
  • International Business Machines Corporation (IBM)
  • Tata Consultancy Services Limited
  • Amazon Web Services
  • Schrodinger LLC.
  • Boehringer Ingelheim International GmbH
  • CORE INFORMATICS
  • Informatics Matters Ltd.,

Recent Developments in the Market:

  • In February 2023, Insilico Medicine, a clinical-stage company specializing in end-to-end generative artificial intelligence (AI)-driven drug discovery, has attained FDA Orphan Drug Designation for a drug designed and discovered using generative AI, specifically targeted for idiopathic pulmonary fibrosis.
  • In February 2023, Evotec SE has extended its integrated multi-target drug discovery partnership with the data-driven biotech creation firm, Related Sciences. The collaboration is set to expand the joint portfolio of drug development candidates until 2030, harnessing Evotec's exceptional capabilities throughout the entire research and development continuum.

Global Drug Discovery Informatics Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Workflow, Services, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Workflow:

  • Discovery Informatics
  • Biocontent Management

By Services:

  • Sequence Analysis Platforms
  • Molecular Modelling
  • Docking
  • Clinical Trial Data Management
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Drug Discovery Informatics Market, by region, 2020-2030 (USD Billion)
    • 1.2.2. Drug Discovery Informatics Market, by Workflow, 2020-2030 (USD Billion)
    • 1.2.3. Drug Discovery Informatics Market, by Services, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Drug Discovery Informatics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Drug Discovery Informatics Market Dynamics

  • 3.1. Drug Discovery Informatics Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. High R&D expenditure by pharmaceutical and biotechnology companies
      • 3.1.1.2. Increasing technological advancement in drug discovery platforms
      • 3.1.1.3. Rising pre-clinical research and development
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Drug Discovery Informatics
      • 3.1.2.2. Data Security and Privacy Concerns
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancements in data mining and analytics
      • 3.1.3.2. Rising number of drug discovery activities

Chapter 4. Global Drug Discovery Informatics Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Drug Discovery Informatics Market, by Workflow

  • 5.1. Market Snapshot
  • 5.2. Global Drug Discovery Informatics Market by Workflow, Performance - Potential Analysis
  • 5.3. Global Drug Discovery Informatics Market Estimates & Forecasts by Workflow 2020-2030 (USD Billion)
  • 5.4. Drug Discovery Informatics Market, Sub Segment Analysis
    • 5.4.1. Discovery Informatics
    • 5.4.2. Biocontent Management

Chapter 6. Global Drug Discovery Informatics Market, by Services

  • 6.1. Market Snapshot
  • 6.2. Global Drug Discovery Informatics Market by Services, Performance - Potential Analysis
  • 6.3. Global Drug Discovery Informatics Market Estimates & Forecasts by Services 2020-2030 (USD Billion)
  • 6.4. Drug Discovery Informatics Market, Sub Segment Analysis
    • 6.4.1. Sequence Analysis Platforms
    • 6.4.2. Molecular Modelling
    • 6.4.3. Docking
    • 6.4.4. Clinical Trial Data Management
    • 6.4.5. Others

Chapter 7. Global Drug Discovery Informatics Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Drug Discovery Informatics Market, Regional Market Snapshot
  • 7.4. North America Drug Discovery Informatics Market
    • 7.4.1. U.S. Drug Discovery Informatics Market
      • 7.4.1.1. Workflow breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. Services breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Drug Discovery Informatics Market
  • 7.5. Europe Drug Discovery Informatics Market Snapshot
    • 7.5.1. U.K. Drug Discovery Informatics Market
    • 7.5.2. Germany Drug Discovery Informatics Market
    • 7.5.3. France Drug Discovery Informatics Market
    • 7.5.4. Spain Drug Discovery Informatics Market
    • 7.5.5. Italy Drug Discovery Informatics Market
    • 7.5.6. Rest of Europe Drug Discovery Informatics Market
  • 7.6. Asia-Pacific Drug Discovery Informatics Market Snapshot
    • 7.6.1. China Drug Discovery Informatics Market
    • 7.6.2. India Drug Discovery Informatics Market
    • 7.6.3. Japan Drug Discovery Informatics Market
    • 7.6.4. Australia Drug Discovery Informatics Market
    • 7.6.5. South Korea Drug Discovery Informatics Market
    • 7.6.6. Rest of Asia Pacific Drug Discovery Informatics Market
  • 7.7. Latin America Drug Discovery Informatics Market Snapshot
    • 7.7.1. Brazil Drug Discovery Informatics Market
    • 7.7.2. Mexico Drug Discovery Informatics Market
  • 7.8. Middle East & Africa Drug Discovery Informatics Market
    • 7.8.1. Saudi Arabia Drug Discovery Informatics Market
    • 7.8.2. South Africa Drug Discovery Informatics Market
    • 7.8.3. Rest of Middle East & Africa Drug Discovery Informatics Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. PerkinElmer Inc.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Charles River
    • 8.3.3. Infosys Limited
    • 8.3.4. International Business Machines Corporation (IBM)
    • 8.3.5. Tata Consultancy Services Limited
    • 8.3.6. Amazon Web Services
    • 8.3.7. Schrodinger LLC.
    • 8.3.8. Boehringer Ingelheim International GmbH
    • 8.3.9. CORE INFORMATICS
    • 8.3.10. Informatics Matters Ltd.,

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption